Company Overview and News


Add CDTX
to your dashboard

Headline News

Cidara Therapeutics' (CDTX) CEO Jeff Stein on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Good day, ladies and gentlemen, and welcome to Cidara Therapeutic Third Quarter 2017 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, today's conference may be recorded. (24-0)

ROTY Edition 1 Volume 49: Updates From Quarterly Calls And Trades

2017-11-10 seekingalpha
I remind readers of the need to review quarterly results, filings, and conference calls to monitor changes with their stock holdings. (113-0)

5 Biotech Stocks Well Poised to Surpass Expectations in Q3

2017-11-07 zacks
The Q3 earnings season is approaching its end with 81.2% of the S&P 500 companies having already released results. The majority of players within the medical space have already reported their performance. Per the latest Earnings Trends, total earnings for the medical sector are up 6.5% from the same period last year on 4.6% higher revenues. This year, biotech stocks bounced back strongly after the drug pricing issue affected last year’s performance. (27-0)

What's in the Cards for Merrimack (MACK) in Q3 Earnings?

2017-11-06 zacks
Merrimack Pharmaceuticals, Inc. (MACK - Free Report) is expected to report third-quarter 2017 results around Nov 8, before market opens. Last quarter, Merrimack missed bottom-line expectations by 57.14%. (85-0)

What's in the Cards for Repros (RPRX) This Earnings Season?

2017-11-06 zacks
Repros Therapeutics Inc.  is expected to report third-quarter 2017 results around Nov 14. Let’s see how things are shaping up for this quarter. (96-0)

T2 Biosystems' (TTOO) CEO John McDonough on Q3 2017 Results - Earnings Call Transcript

2017-11-03 seekingalpha
Greetings, and welcome to the T2 Biosystems' Third Quarter 2017 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. (24-1)

CDTX / Cidara Therapeutics, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-10-28 fintel.io
Cidara Therapeutics, Inc. (NASDAQ:CDTX) has 55 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13,217,456 shares. Largest shareholders include Bb Biotech Ag, FMR LLC / Fidelity Management & Research, Interwest Venture Management Co, Frazier Management Llc, and Aisling Capital LLC. (8-1)

ROTY Volume 1 Edition 42: Thoughts On Underpeformers And New Trades

2017-10-24 seekingalpha
We are also swapping a Contender for a current ROTY holding due to higher perceived upside and an important near term catalyst. (132-6)

Cidara Therapeutics: Buy The Secondary

2017-10-19 seekingalpha
Shares have fallen 35% year to date and are in the red by 12% since my first article. (8-1)

Major Biotech, Pharma and FDA Catalysts Coming in October

2017-09-30 247wallst
Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk involved, should a study come back negative or should a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be massive upside. (212-13)

T2 Biosystems And Aridis Pharma Join

2017-08-15 devicespace
WASHINGTON, Aug. 15, 2017 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of two new members to their group of 12 companies with the mission to combat drug resistant infections and spur life-saving innovations. T2 Biosystems, Inc. (NASDAQ:TTOO), is an emerging leader in the development of innovative diagnostic products to improve patient health, and is AWG's first diagnostic member company. (0-2)

T2 Biosystems and Aridis Pharmaceuticals, Inc. Join Antimicrobials Working Group

2017-08-15 prnewswire
WASHINGTON, Aug. 15, 2017 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of two new members to their group of 12 companies with the mission to combat drug resistant infections and spur life-saving innovations. T2 Biosystems, Inc. (NASDAQ: TTOO), is an emerging leader in the development of innovative diagnostic products to improve patient health, and is AWG's first diagnostic member company.

T2 Biosystems Joins As First Diagnostic Member

2017-07-27 devicespace
LEXINGTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced today that it will join the Antimicrobials Working Group (AWG) as its first diagnostic member. T2 Biosystems joins thirteen antimicrobials companies in their mission to combat drug resistant infections and spur life-saving innovations.

CUSIP: 171757107